Maplight Therapeutics, Inc. · NASDAQ:MPLT

Foff Erin Pennock sold 4,438 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 7, 2026 · Filed May 11, 2026

On May 7, 2026, Foff Erin Pennock (Chief Medical Officer) sold 4,438 Maplight Therapeutics, Inc. shares at an average US$28.54 for US$127K under a trading plan, leaving 346,059 shares. Filed May 11, 2026 (Form 4).

Sold
4,438 shares
Price
US$28.54 average (US$28.52 to US$29.10)
Value
US$127K
Holding after
346,059 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Voting Common StockSale4,321US$28.52346,176Direct
May 7, 2026Voting Common StockSale117US$29.10346,059Direct

Source

View original at SEC

Related